PDS Biotechnology Corporation
PDSB
$1.10
-$0.20-15.39%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.28% | 13.98% | 10.02% | 19.12% | 12.42% |
| Total Depreciation and Amortization | 1.17% | 2.37% | 3.60% | 4.86% | 4.19% |
| Total Amortization of Deferred Charges | 34.31% | 23.05% | 104.58% | 44.88% | 77.44% |
| Total Other Non-Cash Items | -22.53% | -23.32% | -29.64% | -16.21% | -19.11% |
| Change in Net Operating Assets | 93.34% | -40.93% | -118.53% | -255.87% | -2,787.45% |
| Cash from Operations | 20.78% | 8.42% | 0.18% | -12.30% | -4.14% |
| Capital Expenditure | -- | 100.00% | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | 100.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -708.85% | -49,345.60% | -48,581.46% | -11,982.57% | -5,254.88% |
| Issuance of Common Stock | -40.16% | -56.77% | -61.72% | -66.61% | 42.18% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -36.72% | -71.64% | -73.05% | -76.44% | 23.28% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -0.72% | -423.37% | -794.42% | -1,957.55% | 13.84% |